Results from the pivotal EV-303 trial demonstrated that, when used before and after surgery, the combination reduced the risk of recurrence, progression or death by 60% and the risk of death by 50% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback